DOI: 10.1055/s-00000004

Aktuelle Neurologie

References

Daniels GB, Vladic A, Brinar V. et al.
Alemtuzumab-related thyroid dysfunction in a phase 2 trial of patients with relapsing-remitting multiple sclerosis.

J Clin Endocrinol Metabol 2014;
99: 80-89

Download Bibliographical Data

Access:
Access: